Form 4: Boston Scientific Director Ludwig Exercises Options and Sells Shares
SEC Form 4 Filing
Director Edward J. Ludwig of Boston Scientific Corp. exercised stock options and sold shares on April 26, 2024.
Summary
- On April 26, 2024, Edward J. Ludwig, a director of Boston Scientific Corp (BSX), exercised stock options to acquire 9,818 shares of common stock at a price of $17.37 per share.
- Simultaneously, Ludwig sold 9,818 shares of common stock at a price of $73.2901 per share.
- Following these transactions, Ludwig directly owns 41,374 shares of Boston Scientific Corp.
- The exercised stock options were granted on May 3, 2016, and vested in full on that date.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by a company director. There's no indication of positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for directors and officers of publicly traded companies. It provides transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small portion of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 05/03/2016 | Date of the Company's 2016 annual meeting of stockholders and the date the stock options vested in full. |
| 04/26/2024 | Date of transaction: Ludwig exercised stock options and sold shares. |
| 04/29/2024 | Date of signature on the Form 4 filing. |
| 05/05/2025 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.